Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Tvardi Therapeutics, Inc., Common Stock

TVRD

NAQ

$29.09

-$3.79

(-11.53%)

Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Overview Returns Financials Ratios News FAQs

Price Chart

Key Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$272.31M

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

63.86K

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$8.14 L

$34.31 H

$29.09

About Tvardi Therapeutics, Inc., Common Stock

Tvardi Therapeutics, Inc. operates as a biotechnology company that develops medicines for cancer, chronic inflammation diseases, and fibrosis diseases. It develops inhibitors of STAT3, a molecule implicated in the initiation and progression of cancer and fibrosis. Its pipeline includes TTI-101, a small-molecule inhibitor of signal transducers and activators of transcription; and TTI-109, a STAT3 inhibitor for clinical use, including tolerability, bioavailability, and potency. Tvardi Therapeutics, Inc. was incorporated in 2017 and is based in Sugar Land, Texas. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time Frame	TVRD	Sector	S&P500
1-Week Return	15.3%	-1.91%	-1.87%
1-Month Return	57.41%	-3.82%	8.93%
3-Month Return	93.55%	-11.56%	-2.39%
6-Month Return	164.94%	-10.21%	-2.41%
1-Year Return	10.09%	-9.91%	10.88%
3-Year Return	-90.55%	-0.28%	46.93%
5-Year Return	-95.05%	31.29%	94.89%
10-Year Return	-91.59%	75.9%	177.5%

Time Frame	TVRD	Sector	S&P500
1-Week Return	167,377.60%	-63.42%	-62.63%
1-Month Return	24,858.96%	-37.74%	183.11%
3-Month Return	1,355.81%	-39.24%	-9.34%
6-Month Return	621.19%	-19.62%	-4.83%
1-Year Return	10.09%	-9.91%	10.88%
3-Year Return	-54.45%	-0.09%	13.69%
5-Year Return	-45.18%	5.60%	14.28%
10-Year Return	-21.93%	5.81%	10.75%

Financials

	Dec '22	Dec '23
Total Revenue	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Profit	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Margin	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Operating Expenses	21.19M	18.66M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":88.07,"profit":true}]
Operating Income	(21.19M)	(18.66M)	[{"date":"2022-12-31","value":-2119300000,"profit":false},{"date":"2023-12-31","value":-1866500000,"profit":false}]
Total Non-Operating Income/Expense	1.30M	2.64M	[{"date":"2022-12-31","value":49.39,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income	(20.54M)	(17.35M)	[{"date":"2022-12-31","value":-2054200000,"profit":false},{"date":"2023-12-31","value":-1734700000,"profit":false}]
Income Taxes	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Income From Continuous Operations	(20.54M)	(17.35M)	[{"date":"2022-12-31","value":-2054200000,"profit":false},{"date":"2023-12-31","value":-1734700000,"profit":false}]
Income From Discontinued Operations	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	(20.54M)	(17.35M)	[{"date":"2022-12-31","value":-2054200000,"profit":false},{"date":"2023-12-31","value":-1734700000,"profit":false}]

EPS (Diluted)	(57.34)	(78.78)	[{"date":"2022-12-31","value":-5734.13,"profit":false},{"date":"2023-12-31","value":-7877.94,"profit":false}]

	Dec '22	Dec '23
Total Revenue	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Profit	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Margin	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Operating Expenses	-	(11.93%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Operating Income	-	(11.93%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Total Non-Operating Income/Expense	-	102.46%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income	-	(15.55%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Income Taxes	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Income From Continuous Operations	-	(15.55%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Income From Discontinued Operations	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	-	(15.55%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]

EPS (Diluted)	-	37.39%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

	Dec '23	Mar '24	Mar '25
Total Revenue	-	2.13M	2.57M	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":83.11,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Cost of Revenue	-	620.00K	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Gross Profit	-	1.51M	2.57M	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":58.97,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Gross Margin	-	70.96%	100.00%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":70.96,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]

Operating Expenses	4.66M	29.40M	4.96M	[{"date":"2023-12-31","value":15.86,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":16.85,"profit":true}]
Operating Income	(4.66M)	(27.27M)	(2.39M)	[{"date":"2023-12-31","value":-466400000,"profit":false},{"date":"2024-03-31","value":-2726500000,"profit":false},{"date":"2025-03-31","value":-238600000,"profit":false}]
Total Non-Operating Income/Expense	626.00K	(3.43M)	(2.52M)	[{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":-548.08,"profit":false},{"date":"2025-03-31","value":-402.56,"profit":false}]
Pre-Tax Income	(4.35M)	(30.70M)	(4.91M)	[{"date":"2023-12-31","value":-435100000,"profit":false},{"date":"2024-03-31","value":-3069600000,"profit":false},{"date":"2025-03-31","value":-490600000,"profit":false}]
Income Taxes	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Income After Taxes	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]

Income From Continuous Operations	(4.35M)	(30.70M)	(4.91M)	[{"date":"2023-12-31","value":-435100000,"profit":false},{"date":"2024-03-31","value":-3069600000,"profit":false},{"date":"2025-03-31","value":-490600000,"profit":false}]
Income From Discontinued Operations	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Net Income	(4.35M)	(30.70M)	(4.91M)	[{"date":"2023-12-31","value":-435100000,"profit":false},{"date":"2024-03-31","value":-3069600000,"profit":false},{"date":"2025-03-31","value":-490600000,"profit":false}]

EPS (Diluted)	(21.37)	(20.24)	(5.04)	[{"date":"2023-12-31","value":-2136.89,"profit":false},{"date":"2024-03-31","value":-2024.35,"profit":false},{"date":"2025-03-31","value":-503.96,"profit":false}]

	Dec '23	Mar '24	Mar '25
Total Revenue	-	-	20.33%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Cost of Revenue	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Gross Profit	-	-	69.57%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Gross Margin	-	-	40.92%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":100,"profit":true}]

Operating Expenses	-	530.36%	(83.15%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":-15.68,"profit":false}]
Operating Income	-	484.58%	(91.25%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":-18.83,"profit":false}]
Total Non-Operating Income/Expense	-	(648.08%)	(26.55%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false}]
Pre-Tax Income	-	605.49%	(84.02%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":-13.88,"profit":false}]
Income Taxes	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Income After Taxes	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]

Income From Continuous Operations	-	605.49%	(84.02%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":-13.88,"profit":false}]
Income From Discontinued Operations	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Net Income	-	605.49%	(84.02%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":-13.88,"profit":false}]

EPS (Diluted)	-	(5.27%)	(75.11%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false}]

	Dec '22	Dec '23
Total Assets
Current Assets	44.11M	26.16M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":59.3,"profit":true}]
Non-current Assets	988.00K	843.00K	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":85.32,"profit":true}]
Total Assets	45.10M	27.00M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":59.87,"profit":true}]

Total Liabilities
Current Liabilities	4.28M	3.28M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":76.71,"profit":true}]
Non-current Liabilities	85.87M	85.78M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":99.89,"profit":true}]
Total Liabilities	90.15M	89.06M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":98.79,"profit":true}]

Total Shareholders' equity
Common Stock	19.00K	19.00K	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Retained Earnings	(45.49M)	(62.84M)	[{"date":"2022-12-31","value":-4549200000,"profit":false},{"date":"2023-12-31","value":-6283900000,"profit":false}]
Other Stockholders' Equity	446.00K	762.00K	[{"date":"2022-12-31","value":58.53,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Shareholders' equity	(45.05M)	(62.06M)	[{"date":"2022-12-31","value":-4505100000,"profit":false},{"date":"2023-12-31","value":-6205800000,"profit":false}]

Total Liabilities & Shareholders Equity	45.10M	27.00M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":59.87,"profit":true}]

	Dec '22	Dec '23
Total Assets
Current Assets	-	(40.70%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Non-current Assets	-	(14.68%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Total Assets	-	(40.13%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]

Total Liabilities
Current Liabilities	-	(23.29%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Non-current Liabilities	-	(0.11%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Total Liabilities	-	(1.21%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]

Total Shareholders' equity
Common Stock	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Retained Earnings	-	38.13%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Other Stockholders' Equity	-	70.85%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Shareholders' equity	-	37.75%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	(40.13%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]

	Dec '23	Sep '24	Mar '25
Total Assets
Current Assets	26.16M	10.70M	38.95M	[{"date":"2023-12-31","value":67.16,"profit":true},{"date":"2024-09-30","value":27.48,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Non-current Assets	843.00K	1.81M	-	[{"date":"2023-12-31","value":46.55,"profit":true},{"date":"2024-09-30","value":100,"profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Total Assets	27.00M	12.51M	38.95M	[{"date":"2023-12-31","value":69.33,"profit":true},{"date":"2024-09-30","value":32.13,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	3.28M	5.31M	1.20M	[{"date":"2023-12-31","value":61.82,"profit":true},{"date":"2024-09-30","value":100,"profit":true},{"date":"2025-03-31","value":22.59,"profit":true}]
Non-current Liabilities	85.78M	85.71M	45.82M	[{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-09-30","value":99.92,"profit":true},{"date":"2025-03-31","value":53.42,"profit":true}]
Total Liabilities	89.06M	91.02M	47.02M	[{"date":"2023-12-31","value":97.85,"profit":true},{"date":"2024-09-30","value":100,"profit":true},{"date":"2025-03-31","value":51.66,"profit":true}]

Total Shareholders' equity
Common Stock	19.00K	19.00K	-	[{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-09-30","value":100,"profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Retained Earnings	(62.84M)	(79.53M)	(760.52M)	[{"date":"2023-12-31","value":-6283900000,"profit":false},{"date":"2024-09-30","value":-7952900000,"profit":false},{"date":"2025-03-31","value":-76051800000,"profit":false}]
Other Stockholders' Equity	762.00K	1.01M	-	[{"date":"2023-12-31","value":75.67,"profit":true},{"date":"2024-09-30","value":100,"profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Total Shareholders' equity	(62.06M)	(78.50M)	(8.07M)	[{"date":"2023-12-31","value":-6205800000,"profit":false},{"date":"2024-09-30","value":-7850300000,"profit":false},{"date":"2025-03-31","value":-807300000,"profit":false}]

Total Liabilities & Shareholders Equity	27.00M	12.51M	38.95M	[{"date":"2023-12-31","value":69.33,"profit":true},{"date":"2024-09-30","value":32.13,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]

	Dec '23	Sep '24	Mar '25
Total Assets
Current Assets	-	(59.08%)	263.89%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":-22.39,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]
Non-current Assets	-	114.83%	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":100,"profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Total Assets	-	(53.65%)	211.23%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":-25.4,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	-	61.75%	(77.41%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":100,"profit":true},{"date":"2025-03-31","value":-125.36,"profit":false}]
Non-current Liabilities	-	(0.08%)	(46.54%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false}]
Total Liabilities	-	2.20%	(48.34%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":100,"profit":true},{"date":"2025-03-31","value":-2198.7,"profit":false}]

Total Shareholders' equity
Common Stock	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Retained Earnings	-	26.56%	856.28%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":3.1,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Other Stockholders' Equity	-	32.15%	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":100,"profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Total Shareholders' equity	-	26.50%	(89.72%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":100,"profit":true},{"date":"2025-03-31","value":-338.56,"profit":false}]

Total Liabilities & Shareholders Equity	-	(53.65%)	211.23%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":-25.4,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]

	Dec '22	Dec '23
Operating Activities
Net Operating Cash Flow	(17.87M)	(21.04M)	[{"date":"2022-12-31","value":-1786600000,"profit":false},{"date":"2023-12-31","value":-2104000000,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	4.00K	2.00K	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":50,"profit":true}]

Net Change in Cash	(39.86M)	1.43M	[{"date":"2022-12-31","value":-2787.55,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	(17.92M)	(21.04M)	[{"date":"2022-12-31","value":-1791600000,"profit":false},{"date":"2023-12-31","value":-2104000000,"profit":false}]

	Dec '22	Dec '23
Operating Activities
Net Operating Cash Flow	-	17.77%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	(50.00%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]

Net Change in Cash	-	(103.59%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	17.44%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

	Dec '23	Mar '24	Mar '25
Operating Activities
Net Operating Cash Flow	(5.75M)	(30.45M)	(4.69M)	[{"date":"2023-12-31","value":-574900000,"profit":false},{"date":"2024-03-31","value":-3045300000,"profit":false},{"date":"2025-03-31","value":-469200000,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	(685.00K)	1.01M	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":-68.09,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]

Net Change in Cash	(5.75M)	(5.19M)	(3.69M)	[{"date":"2023-12-31","value":-574900000,"profit":false},{"date":"2024-03-31","value":-518700000,"profit":false},{"date":"2025-03-31","value":-368600000,"profit":false}]

Free Cash Flow
Free Cash Flow	(5.75M)	(31.29M)	(4.69M)	[{"date":"2023-12-31","value":-574900000,"profit":false},{"date":"2024-03-31","value":-3128900000,"profit":false},{"date":"2025-03-31","value":-469200000,"profit":false}]

	Dec '23	Mar '24	Mar '25
Operating Activities
Net Operating Cash Flow	-	429.71%	(84.59%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":-19.69,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	-	(246.86%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":null,"profit":false}]

Net Change in Cash	-	(9.78%)	(28.94%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	444.25%	(85.00%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":-19.13,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

	TVRD
Current Ratio	32.48
Quick Ratio	31.73

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	TVRD
ROA (LTM)	0.00%
ROE (LTM)	0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	TVRD
Debt Ratio Lower is generally better. Negative is bad.	1.21
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	-0.21

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	TVRD
Trailing PE	NM
Forward PE	NM
P/S (TTM)	0.00
P/B	0.00
EV/R	0.00
EV/Ebitda	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Tvardi Therapeutics, Inc. share price today?

Tvardi Therapeutics, Inc. (TVRD) share price today is $29.09

Can Indians buy Tvardi Therapeutics, Inc. shares?

Yes, Indians can buy shares of Tvardi Therapeutics, Inc. (TVRD) on Vested. To buy Tvardi Therapeutics, Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in TVRD stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Tvardi Therapeutics, Inc. be purchased?

Yes, you can purchase fractional shares of Tvardi Therapeutics, Inc. (TVRD) via the Vested app. You can start investing in Tvardi Therapeutics, Inc. (TVRD) with a minimum investment of $1.

How to invest in Tvardi Therapeutics, Inc. shares from India?

You can invest in shares of Tvardi Therapeutics, Inc. (TVRD) via Vested in three simple steps:

Click on Sign Up or Invest in TVRD stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Tvardi Therapeutics, Inc. shares

What is Tvardi Therapeutics, Inc. 52-week high and low stock price?

The 52-week high price of Tvardi Therapeutics, Inc. (TVRD) is $34.31. The 52-week low price of Tvardi Therapeutics, Inc. (TVRD) is $8.14.

What is Tvardi Therapeutics, Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Tvardi Therapeutics, Inc. (TVRD) is 0.00

What is the Market Cap of Tvardi Therapeutics, Inc.?

The market capitalization of Tvardi Therapeutics, Inc. (TVRD) is $272.31M

What is Tvardi Therapeutics, Inc.’s stock symbol?

The stock symbol (or ticker) of Tvardi Therapeutics, Inc. is TVRD